In a breakthrough study published in Cell Reports, researchers from Professor Idit Shachar’s laboratory at the Weizmann Institute of Science have...
Vous n'êtes pas connecté
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
In a breakthrough study published in Cell Reports, researchers from Professor Idit Shachar’s laboratory at the Weizmann Institute of Science have...
A study published in Clinical Cancer Research confirmed that tissue stiffening in the most common types of breast cancer, HER2-negative, can...
Using a gene signature technique to tailor chemotherapy for patients with early triple-negative breast cancer shows promise as a way to improve...
WEDNESDAY, Oct. 30, 2024 -- For patients with operative triple-negative breast cancer, a multigene signature can help tailor adjuvant chemotherapy,...
Researchers at Baylor College of Medicine and Washington University School of Medicine in St. Louis, USA, have identified clinical and genetic...
MILAN, Nov. 1, 2024. Diadem SpA, in partnership with researchers from the University of Texas Medical Branch, led by Prof. Rakez Kayed from the...
The ownership of the Koombana Bay groynes and an inquest into expanding a much-needed breast cancer clinic in Bunbury have been approved by the City...
Researchers have identified 22 pesticides consistently associated with the incidence of prostate cancer in the United States, with four of the...
Although breast cancer is the most common non-skin cancer diagnosed in women, finding support during treatment and through survivorship can be...
A recent study led by Cedars-Sinai researchers reveals that a growing number of older men in the U.S. with intermediate or high-risk prostate cancer...